Received May 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Shingrix is mixed with a plain diluent; Shingrix is mixed with a plain diluent; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution (Verbatim: Shingrix is mixed with a plain diluent) and inappropriate dose of vaccine administered (Verbatim: Shingrix is mixed with a plain diluent). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 08-May-2025 Physician asked that Shingrix was mixed with a plain diluent and not the one it comes with, what should they do. When the Medical Information Specialist tried to clarify if that was a hypothetical question or a real scenario, visitor ended the chat, so the Adverse Event report was being send as a preventive measure, only for awareness, since it might be a potential administration of Shingrix after reconstitution with an unapproved diluent. Reporter did not clarified what type of Healthcare Provider they were, and they declined consent to record their contact details into the system. Shingrix reconstituted with plain diluent instead of the supplied liquid conjugate, which led to Wrong solution used in drug reconstitution and Inappropriate dose of vaccine administered.